Safety of 5914 intravitreal ziv-aflibercept injections.
Sumit Randhir SinghMichael W StewartGoura ChattannavarMohammed AshrafAhmed A R SoukaMazen ElDardeeryNeeraj WadhwaChintan SarvaiyaAhmad M MansourAmeen MarashiSuresh RamchandaniImoro Zeba BraimahMohammad Hossein Jabbarpoor BonyadiAlireza RamezaniMasoud SoheilianJoão Rafael de Oliveira DiasGabriel Costa de AndradeAndré MaiaEduardo Büchele RodriguesMichel Eid FarahAlay BankerJay Chhablaninull nullPublished in: The British journal of ophthalmology (2018)
This constitutes the largest pooled safety report on IVZ use and includes patients from 14 centres distributed across the globe. It shows that IVZ has an acceptable ocular and systemic safety profile with incidences of adverse events similar to those of other vascular endothelial growth factor inhibitory drugs. The analysis supports the continued use of IVZ in various retinal disorders.